Novo Nordisk A/S (NVO) Reports Positive Results From First Phase 3 Trial With Long-Acting Factor IX for Treatment of Hemophilia B
5/17/2013
More...
|
Sanofi (France) (SAN.PA) Plans to File JAK2 Inhibitor After Positive Phase III
5/17/2013
More...
|
Roche (RHHBY) Banks on New Drug Data to Defend Cancer Business
5/16/2013
More...
|
AstraZeneca PLC (AZN) Advances Three Cancer Drugs Into Late-Stage Trials
5/16/2013
More...
|
Genentech (RHHBY) Cancer Antibody, Son of Rituxan, Nails Pivotal Study
5/16/2013
More...
|
Sanofi (France) (SAN.PA) and Regeneron Pharmaceuticals, Inc. (REGN) Announce Patient Enrollment in Two Phase 3 Trials with Sarilumab in Rheumatoid Arthritis (RA)
5/15/2013
More...
|
Medivir AB (MVIRb.F): FDA Grants Priority Review to Simeprevir for Combination Treatment of Genotype 1 Chronic Hepatitis C
5/13/2013
More...
|
Medivir AB (MVIRb.F) Release: FDA Grants Priority Review to Simeprevir for Combination Treatment of Genotype 1 Chronic Hepatitis C
5/13/2013
More...
|
Actelion Ltd. (ALIOF.PK) Gets Go-Ahead to Continue New Drug Trial
5/8/2013
More...
|
Celgene Corporation (CELG) Release: Apremilast Achieves Statistical Significance for the Primary and Major Secondary Endpoints in Fourth Pivotal Phase III Study (PALACE 4) of Patients With Psoriatic Arthritis
5/7/2013
More...
|
Basilea Pharmaceutica (BSLN.SW) Reports Presentation of New Data on Anti-Infective Drug Candidates Addressing Drug Resistance
4/29/2013
More...
|
Active Biotech AB (BTPC) and Ipsen (IPN.PA) Update the Analysis Plan for the 10TASQ10 Trial Evaluating Tasquinimod in the Treatment of Prostate Cancer
4/25/2013
More...
|
Data From Phase 3 Studies of Gilead Sciences, Inc. (GILD)'s Sofosbuvir for Hepatitis C in the Forefront
4/23/2013
More...
|
Astellas Pharma Inc. (YPH.BE), GlaxoSmithKline (GSK) Vie to Make "High Altitude" Anemia Pill
4/22/2013
More...
|
SCM Pharma Limited Supports Clinical Scale-Up for Varisolve®
4/22/2013
More...
|
Teva Pharmaceutical Industries Limited (TEVA) Presented New Data From Phase III Clinical Trial of Milprosa™ (Progesterone) Vaginal Ring at the 61st Annual Meeting of the Pacific Coast Reproductive Society
4/17/2013
More...
|
Forest Laboratories, Inc. (FRX) and Almirall Report Positive COPD Drug Data
4/16/2013
More...
|
InDex Pharmaceuticals AB Completes Patient Recruitment in P3 Ulcerative Colitis Study With Kappaproct
4/8/2013
More...
|
Medivation, Inc. (MDVN) and Astellas Pharma Inc. (YPH.BE) Provide Update on PREVAIL
4/1/2013
More...
|
Sanofi (France) (SAN.PA)'s Lemtrada MS Drug Effective in Extension Trial
3/22/2013
More...
|
Teva Pharmaceutical Industries Limited (TEVA) and Active Biotech AB (BTPC) See Positive Results From MS Study
3/21/2013
More...
|
Adocia Announces Its Phase III Development Program for the Treatment of Diabetic Foot Ulcer
3/20/2013
More...
|
Novo Nordisk A/S (NVO) Pleased With Obesity Trial Results
3/19/2013
More...
|
AOP Orphan Pharmaceuticals AG Release: Essential Thrombocythemia (ET) – Convincing Data of ANAHYDRET Study Now Published
3/18/2013
More...
|
R-Tech Ueno: Start of the Patient Enrollment of a Phase 3 Clinical Study of Unoprostone (Development Code UF-021) Ophthalmic Solution for the Treatment of Retinitis Pigmentosa
3/18/2013
More...
|
Sinovac Biotech Ltd. (SVA) Vaccine for Hand, Foot and Mouth Disease Meets Study Goal
3/15/2013
More...
|
Marinomed Biotechnologie GmbH Release: Antiviral Nasal Spray - Data From Two Clinical Studies Prove Effectiveness of Marinomed's Antiviral Drug
3/15/2013
More...
|
BioAlliance Pharma Pursues the Development Plan of Its Loramyc® in Japan Through Its Partner Sosei
3/12/2013
More...
|
Gilead Sciences, Inc. (GILD) Drug Reduces Chest Pain Episodes in Diabetics: Study
3/11/2013
More...
|
Eisai Inc. (ESALF.PK) Slams German Decision on Fycompa; Takeda Pharmaceutical Co. Ltd. (TKPYY) Files Vedolizumab With European Medicines Agency
3/11/2013
More...
|
Teva Pharmaceutical Industries Limited (TEVA) Holds Its Breath During Third Phase 3 Trial
3/8/2013
More...
|
Bayer AG (BAY.F), Johnson & Johnson (JNJ) Eye Wider Use for Xarelto With New Trials
3/8/2013
More...
|
UCB, Inc. (UCBJF.PK) Had Positive Trial for Vimpat as Monotherapy
3/5/2013
More...
|
Teva Pharmaceutical Industries Limited (TEVA) Publishes Results From Milprosa Phase 3
3/4/2013
More...
|
Boehringer Ingelheim Corporation Announces Initiation of Pivotal Trial Investigating Volasertib in Patients With Acute Myeloid Leukaemia
2/28/2013
More...
|
Alchemia Completes Enrolment in Pivotal Phase III HA-Irinotecan Trial of Metastatic Colorectal Cancer
2/28/2013
More...
|
Merck KGaA (MKGAF.PK) Drug Fails in Late-Stage Brain Cancer Trial
2/26/2013
More...
|
ANTISENSE PHARMA GmbH Announces Revised Development Path for Trabedersen
2/26/2013
More...
|
CEL-SCI (CVM) Announces Initiation of New Sites for Multikine Phase III Clinical Study for Head and Neck Cancer in Taiwan
2/25/2013
More...
|
Algeta: Further Sub-Analyses of ALSYMPCA Phase III Study Presented at 2013 Genitourinary Cancers Symposium
2/15/2013
More...
|
Astellas Pharma Inc. (YPH.BE) and AVEO Oncology (Formerly known as AVEO Pharmaceuticals, Inc.) (AVEO) Report Positive Kidney Cancer Drug Trial Data
2/14/2013
More...
|
Pozen, Inc. (POZN) Presents Positive Phase 3 Results
2/8/2013
More...
|
Biogen Idec, Inc. (Massachusetts) (BIIB) Release: New Phase 3 Data Reinforce Long-Lasting Protection From Bleeding for Patients With Hemophilia A and B
2/8/2013
More...
|
Genentech (RHHBY) Says Blood Cancer Drug Met Stage One Goal
2/4/2013
More...
|
Celgene (CELG)'s Abraxane Keeps Pancreatic Pts Alive an Extra Two Months in Trial
1/24/2013
More...
|
Teva Pharmaceutical Industries Limited (TEVA)'s NUVIGIL® Fails Phase 3 Trial Again
1/23/2013
More...
|
Synthon Biopharmaceuticals Reports Positive Early Results With Its Second Generation HER2-Antibody-Drug Conjugate
1/22/2013
More...
|
Amarin Corporation PLC (AMRN) Announces Publication of Additional Inflammatory Marker Data From MARINE and ANCHOR Phase 3 Clinical Trials in the American Journal of Cardiovascular Drugs
1/22/2013
More...
|
Boehringer Ingelheim Corporation Enrolls First Patients in Pivotal Phase III Interferon-Free Hepatitis C Trial Program
1/17/2013
More...
|
Eisai Company, Ltd. (ESALY.PK)'s Farletuzumab Fails Ovarian Cancer Trial
1/15/2013
More...
|
Zhifei Biological Products Approved to Begin China Phase III Trial of TB Vaccine
1/11/2013
More...
|
Boehringer Ingelheim Corporation, Eli Lilly and Company (LLY) Say Diabetes Drug Meets Goals in Later Trials
1/9/2013
More...
|
Celgene International Sárl (CELG) Release: Apremilast ESTEEM Program Meets Primary and Major Secondary Endpoint in Pivotal Phase III Psoriasis Trials
1/7/2013
More...
|
Amicus Therapeutics, Inc. (FOLD), GlaxoSmithKline (GSK) Say Treatment Misses Goal
12/20/2012
More...
|
Morrison & Foerster Launches MoFo BioMeter, a Quarterly Index Charting Health of the Biotech Industry
12/20/2012
More...
|
Medivir AB (MVIRb.F) Announces Phase III Data for Simeprevir Demonstrating Efficacy and Safety in Genotype 1 Hepatitis C Patients
12/20/2012
More...
|
BioAlliance Pharma: First Meeting of the DSMB of the ReLive Trial and Continuation Without Modification of the Phase III Clinical Trial With Livatag® in Primary Liver Cancer
12/20/2012
More...
|
Novo Nordisk A/S (NVO) - The Final Phase 3a Trial for IDegLira Completed, and FIAsp Approved for Phase 3 Development
12/19/2012
More...
|
PATH Release: Kala-azar Treatment Completes Phase 3(b) Clinical Trial in Bangladesh
12/17/2012
More...
|
Basilea Pharmaceutica (BSLN.SW) Reports Recruitment Completion of Phase 3 Pivotal Study of Isavuconazole, an Agent for the Potential Primary Treatment of Invasive and Life-Threatening Fungal Infections
12/14/2012
More...
|
FibroGen, Inc. and Astellas Pharma Inc. (YPH.BE) Announce Initiation of Phase 3 Trial of FG-4592/ASP1517 for Treatment of Anemia of Chronic Kidney Disease
12/12/2012
More...
|
Novartis AG (NVS) Says Trial Results Back Tasigna Drug
12/11/2012
More...
|
Boehringer Ingelheim Corporation to Initiate Phase III Study in Leukemia With its Compound Volasertib* Based on Positive Phase II Results
12/10/2012
More...
|
Active Biotech AB (BTPC) and Ipsen (IPN.PA) Announce Completion of Recruitment of Tasquinimod Clinical Phase III Study in Prostate Cancer
12/10/2012
More...
|
BioAlliance Pharma: First Meeting of the DSMB of the ReLive Trial and Continuation Without Modification of the Phase III Clinical Trial With Livatag® in Primary Liver Cancer
12/6/2012
More...
|
GlaxoSmithKline (GSK) Hopes for 14 New Drug Successes in 2013-14
12/4/2012
More...
|
GENFIT Corp. (ALGFT) Release: First Nash Patients Treated With GFT505 in the U.S.A. and in Europe
11/20/2012
More...
|
GlaxoSmithKline (GSK)-Pfizer Inc. (PFE) HIV Drug Helps Hard-to-Treat Patients
11/15/2012
More...
|
ViiV Healthcare Says Phase III Data From VIKING-3 Dolutegravir Study Encouraging
11/14/2012
More...
|
Merck & Co., Inc. (MRK) Release: ISENTRESS® (raltegravir) in Combination Therapy Demonstrated Long-Term Efficacy and Safety in Adult Patients Co-Infected With HIV-1 and Hepatitis B and/or C in a Subgroup Analysis at 240 Weeks
11/14/2012
More...
|
Celgene International Sárl (CELG) Release: Oral Apremilast Achieves Statistical Significance for the Primary Endpoint of ACR20 in the First Phase 3 Study (Palace-1) in Patients With Psoriatic Arthritis
11/13/2012
More...
|
UCB Group (UCBJF.PK) Release: RAPID™ -axSpA Study Showed Certolizumab Pegol Reduced Signs and Symptoms of Axial Spondyloarthritis
11/13/2012
More...
|
GlaxoSmithKline (GSK) Malaria Vaccine Suffers Setback
11/12/2012
More...
|
Phase III Data for Teva Pharmaceutical Industries Limited (TEVA)’s QNASL® (beclomethasone dipropionate) Demonstrate Efficacy Profile in Pediatric Patients With Seasonal Allergic Rhinitis
11/9/2012
More...
|
Novartis AG (NVS) Heart Failure Drug Cuts Death by 37 Pct
11/8/2012
More...
|
immatics biotechnologies GmbH's Renal Cancer Vaccine IMA901 Completes Phase 3 Patient Recruitment and is Granted U.S. Orphan Drug Designation by the FDA
11/8/2012
More...
|
ProFibrix Passes Halfway Mark of Patient Enrolment in Pivotal Phase 3 With Fibrocaps™ and Successfully Concludes Safety Review Assessment
11/8/2012
More...
|
Pharming Group (PHGUF.PK)-Santarus Inc. (SNTS) Ruconest Phase III Study Meets Primary Endpoint
11/7/2012
More...
|
Cryopraxis Release: Cardiac Cell Therapy Phase III Trial to Treat Refractory Angina
11/6/2012
More...
|
Sanofi (France) (SAN.PA) MS Drug Beats Avonex in Head-to-Head
11/2/2012
More...
|
Biogen Idec, Inc. (Massachusetts) (BIIB) Hemophilia Drug Wows in Phase 3 Study
11/1/2012
More...
|
GlaxoSmithKline (GSK) Starts Final-Stage Tests on Severe Asthma Drug
10/29/2012
More...
|
Celgene International Sárl (CELG) Myeloma Treatment Meets Phase 3 Goals
10/24/2012
More...
|
Merck & Co., Inc. (MRK) Release: North American Phase III Trial With Grass Allergy Immunotherapy Tablet Meets Primary Endpoint, FDA Filing Remains Planned for 2013
10/23/2012
More...
|
GlaxoSmithKline (GSK) Says 5 Late-Stage Flu Trials Met Goals
10/22/2012
More...
|
Samsung Corporation Halts Clinical Tests for Biosimilar
10/18/2012
More...
|
Actelion Ltd. (ALIOF.PK)'s Key Drug Halves Risk of Death, Hospitalization
10/18/2012
More...
|
Wilex AG (WL6.DE)'s Kidney Cancer Drug Fails in Late Stage Trial
10/17/2012
More...
|
Teva Pharmaceutical Industries Limited (TEVA) to Present Positive Data for Glatiramer Acetate 40 mg/1 ml Given Three Times Weekly for Relapsing-Remitting Multiple Sclerosis
10/10/2012
More...
|
Sanofi (France) (SAN.PA) Defends Experimental Med at Diabetes Meeting
10/8/2012
More...
|
Grupo Ferrer Internacional S.A. Successfully Completes an Absorption, Tolerability and Safety Study in Juveniles as Young as Two Months of Age for Novel Antibacterial Compound Ozenoxacin
10/5/2012
More...
|
Circassia Limited Initiates Pivotal Phase 3 ToleroMune® Trial in Cat Allergen-Induced Rhinoconjunctivitis
10/4/2012
More...
|
Novo Nordisk A/S (NVO) Study: Degludec Cuts Night-Time Hypoglycemia Risk
10/3/2012
More...
|
Sanofi (France) (SAN.PA)'s Gaucher Pill Meets Goal in Phase 3 Trial
10/2/2012
More...
|
Johnson & Johnson (JNJ) Experimental Diabetes Drug Helps High-Risk Patients
10/2/2012
More...
|
AVEO Oncology (Formerly known as AVEO Pharmaceuticals, Inc.) (AVEO) and Astellas Pharma Inc. (YPH.BE) Announce New Data Presented at ESMO 2012 Congress Demonstrating the Safety and Tolerability Profile of Tivozanib in Patients With Advanced Kidney Cancer
10/1/2012
More...
|
Medivation, Inc. (MDVN) and Astellas Pharma Inc. (YPH.BE) Announce New Data From XTANDI® (enzalutamide) Pivotal Study
10/1/2012
More...
|
Boehringer Ingelheim Corporation Unprecedented Progression-Free Survival Benefit With Afatinib* Associated With Clinically Meaningful Improvements in Life-Limiting Lung Cancer Symptoms and Better Quality of Life
9/28/2012
More...
|
Takeda Global Research & Development Center, Inc. Launches Phase III Clinical Trial in Asia for "TAK-875", a Potential Diabetic Treatment
9/26/2012
More...
|
Biogen Idec, Inc. (Massachusetts) (BIIB) Says Hemophilia B Medicine Reduced Bleeding
9/26/2012
More...
|
Novartis AG (NVS)'s Drug Reduces Heart Failure Deaths
9/25/2012
More...
|
Boehringer Ingelheim Corporation Release: Recruitment Complete for Two Pivotal Phase III Studies of nintedanib* in Patients With Idiopathic Pulmonary Fibrosis
9/24/2012
More...
|
Andromeda Biotech Successfully Completes Patient Recruitment in Phase III Confirmatory Trial for Its Lead Drug, "DiaPep277" for Type 1 Diabetes
9/12/2012
More...
|
Roche (RHHBY) Ramps Up Alzheimer's Drug Trial as Rivals Stumble
9/11/2012
More...
|
GE Healthcare Release: Phase III Results for Investigational Imaging Agent [18F]Flutemetamol Demonstrate Ability to Accurately Detect Beta Amyloid in Living Patients
9/11/2012
More...
|
Celgene International Sárl (CELG) Release: Apremilast Palace Program Demonstrates Robust and Consistent Statistically Significant Clinical Benefit Across Three Pivotal Phase III Studies (PALACE-1, 2 & 3) in Psoriatic Arthritis
9/6/2012
More...
|
Novartis AG (NVS) Cheered by COPD Trial Results
9/5/2012
More...
|
Boehringer Ingelheim Corporation Release: First Phase III Data for Tiotropium in Symptomatic Asthma Patients Treated With ICS/LABA Published in The New England Journal of Medicine
9/4/2012
More...
|
Novartis AG (NVS) to Seek Lung Treatment Launch in Europe, Japan After Phase III Study Goals Were Met
8/30/2012
More...
|
ArQule, Inc. (ARQL) Plunges as Japanese Partner Temporarily Suspends Tivantinib Trial; Stock Down -1.3101 (19.55%) @ 1:19 PM EDT
8/29/2012
More...
|
Amarin Corporation PLC (AMRN) Announces Additional Publication of MARINE Phase 3 Clinical Trial Results in the Journal of Clinical Lipidology
8/29/2012
More...
|
Teva Pharmaceutical Industries Limited (TEVA) Starts New Round of Testing for MS Pill
8/27/2012
More...
|
GlaxoSmithKline (GSK), Johnson & Johnson (JNJ) to Start Rheumatoid Arthritis Drug Trial
8/24/2012
More...
|
GlaxoSmithKline (GSK), Theravance, Inc. (THRX) Complete Phase III Program of LAMA/LABA
8/24/2012
More...
|
Biota, Inc. Announces Inavir Achieves Primary Endpoint in Phase III Prevention Study
8/22/2012
More...
|
GlaxoSmithKline (GSK) Drug Halves Attacks in Hard-to-Treat Asthma
8/20/2012
More...
|
Novartis AG (NVS) Eye Drug Shows Promise in Study
8/17/2012
More...
|
The New England Journal of Medicine Publishes Results From Astellas Pharma Inc. (YPH.BE) and Medivation, Inc. (MDVN)'s Phase 3 AFFIRM Trial of Enzalutamide
8/16/2012
More...
|
Novo Nordisk A/S (NVO)’s Hemophilia Treatment "Blockbuster" Could be a Total Bust
8/15/2012
More...
|
Teva Pharmaceutical Industries Limited (TEVA) to Initiate Third Phase III Trial of Oral Laquinimod for the Treatment of Relapsing Remitting Multiple Sclerosis
8/8/2012
More...
|
AiCuris Promising Drugs Against Herpes Simplex (AIC316) and Human Cytomegalovirus (Letermovir, AIC246) in Preparation for Phase III
8/7/2012
More...
|
Agennix AG Reports Results of FORTIS-M Phase III Trial With Talactoferrin Alfa in Non-Small Cell Lung Cancer
8/7/2012
More...
|
Allergy Therapeutics plc: FDA Clinical Hold Lifted
8/3/2012
More...
|
Pfizer Inc. (PFE), Johnson & Johnson (JNJ) Alzheimer's Drug Fails One of Four Big Trials; Elan Corporation PLC (ELN) Plunges
7/26/2012
More...
|
Roche (RHHBY) Moves Secret Heart Drug to Phase III Trial
7/25/2012
More...
|
Amarin Corporation PLC (AMRN) Announces Publication of ANCHOR Phase 3 Clinical Trial Results in The American Journal of Cardiology
7/24/2012
More...
|
Bristol-Myers Squibb Company (BMY) Drug Fails Liver Cancer Trial
7/23/2012
More...
|
Acucela Inc. and Otsuka Pharmaceutical Co., Ltd. Announce the Initiation of a Phase 3 Clinical Trial to Evaluate Rebamipide Ophthalmic Suspension in Patients With Dry Eye Syndrome
7/19/2012
More...
|
Ironwood Pharmaceuticals Files to Begin China Phase III Trial of Linaclotide
7/18/2012
More...
|
Celgene (CELG) Psoriatic Arthritis Drug Effective in Phase 3 Trial
7/16/2012
More...
|
Genentech (RHHBY), deCODE genetics, Inc. (DCGN) Identify Protective Gene Against Alzheimer's, Cognitive Decline
7/13/2012
More...
|
Eli Lilly and Company (LLY) Schizophrenia Drug Fails Late-stage Trial
7/12/2012
More...
|
Ipsen (IPN.PA) Says Hemophilia Drug Study Suspended by FDA
7/12/2012
More...
|
D&A Pharma: a Retrospective Study on the Use of ALCOVER® in Italy Confirms the Efficacy of the Drug With 81% of Patients Successfully Detoxified
7/11/2012
More...
|
TiGenix Enrolls First Patients in Pivotal Phase III Trial With Lead Product Cx601 in Perianal Fistulas
7/10/2012
More...
|
Pharming Group (PHGUF.PK) Completes Recruitment of RUCONEST(R) US Pivotal Phase III Study
7/5/2012
More...
|
GlaxoSmithKline (GSK), Theravance, Inc. (THRX) Lung Drug Shows Positive Trial Results
7/3/2012
More...
|
Teva Pharmaceutical Industries Limited (TEVA) Announces Progress of Biologic Investigational Drugs Evaluated to Treat Neutropenia in Breast Cancer Patients Undergoing Chemotherapy
7/2/2012
More...
|
GlaxoSmithKline (GSK)'s Melanoma Drug May Extend Survival
6/26/2012
More...
|
Novo Nordisk A/S (NVO) Chooses to Move Semaglutide Into Phase III Trials
6/22/2012
More...
|
Wall Street Doubt Eli Lilly and Company (LLY), Pfizer Inc. (PFE) Alzheimer's Meds
6/21/2012
More...
|
Pharming Group (PHGUF.PK) Announces Presentation of New Ruconest(R) Clinical Data
6/18/2012
More...
|
Teva Pharmaceutical Industries Limited (TEVA) Reports Positive Top-line Results From GALA Phase III Trial
6/15/2012
More...
|
Pharming Group (PHGUF.PK) Updates on Study 1310 and Shares in Issue
6/15/2012
More...
|
Boehringer Ingelheim Corporation Release: New Linagliptin Phase III Data Demonstrate Significant Reductions in Blood Glucose With No Additional Risk of Hypoglycaemia When Combined With Insulin in Patients With Type 2 Diabetes
6/11/2012
More...
|
Zealand Pharma Announces GetGoal Duo 1 and GetGoal-L Phase III Data on Lixisenatide (Lyxumia(R))1 to be Presented at American Diabetes Association
6/11/2012
More...
|
GlaxoSmithKline (GSK) Reports Data From Phase III Study of Once-weekly Albiglutide in Type 2 Diabetes
6/11/2012
More...
|
62% of Childhood Arthritis Patients Were Symptom-free With Novartis AG (NVS)'s ACZ885
6/7/2012
More...
|
FINOX Biotech Relaese: r-FSH Biosimilar Meets Primary Endpoint in Phase III Pivotal Study
6/6/2012
More...
|
Roche (RHHBY) Smart-bomb Breast-Cancer Drug Slows Tumor Growth
6/5/2012
More...
|
GlaxoSmithKline (GSK) Melanoma Drugs Beat Chemo in Pivotal Trials
6/4/2012
More...
|
Roche (RHHBY)'s Avastin Delays Tumor Growth in Ovarian Cancer
6/4/2012
More...
|
Boehringer Ingelheim Corporation Plans to Challenge AstraZeneca PLC (AZN),Roche (RHHBY) in Lung Cancer Battle
6/4/2012
More...
|
Starpharma Holdings Ltd's VivaGel® Phase 3 Trials 60% Enrolled
6/4/2012
More...
|
Medivation, Inc. (MDVN) and Astellas Pharma Inc. (YPH.BE) Announce Enzalutamide Data Relating to Quality of Life Measures and Extension of Time to First Skeletal-Related Event
6/4/2012
More...
|
Celgene Corporation (CELG)'S Paclitaxel Beat Newer Drugs in Breast Cancer Study
6/4/2012
More...
|
Positive Test Boosts Sanofi (France) (SAN.PA) MS Drug Hopes
6/1/2012
More...
|
GlaxoSmithKline (GSK) Diabetes Drug Data Revealed Amid Hostile Takeover
5/29/2012
More...
|
Tranzyme Pharma (TZYM)/Norgine GI Drug Fails Second Late-stage Trial
5/29/2012
More...
|
Andromeda Announces FDA Orphan Drug Designation for DiaPep277 for the Treatment of Type 1 Diabetes With Residual Beta Cell Function
5/29/2012
More...
|
Clinuvel Commences US Phase III Trial of SCENESSE® in Rare Light and UV Disorder
5/22/2012
More...
|
SLA Pharma AG Reports Successful Phase 3 Results for Treatment of Anal Fissure
5/21/2012
More...
|
600 Patients Recruited in Active Biotech AB (BTPC)'s and Ipsen's Tasquinimod Clinical Phase III Study
5/21/2012
More...
|
ArQule, Inc. (ARQL) and Daiichi Sankyo, Inc. (D4S.F) Announce Completion of Patient Recruitment in Phase 3 Clinical Trial of Tivantinib in Non-Small Cell Lung Cancer
5/18/2012
More...
|
Tolerability of Aveo/Astellas Pharma Inc. (YPH.BE) Kidney Cancer Drug Impresses
5/17/2012
More...
|
Newron Pharmaceuticals (NWRN) PD Drug Succeeds in Phase III, $26 Million Zambon Pact Sealed
5/17/2012
More...
|
New Novartis AG (NVS) COPD Drug Beats Placebo Over a Year
5/17/2012
More...
|
Lundbeck Inc. (LUN.CO) Soars on Phase 3 Study Results for Experimental Antidepressant
5/16/2012
More...
|
Takeda Pharmaceutical Co. Ltd. (TKDG.DE) Phase III Crohn's Disease Trial Meets Primary Endpoints
5/15/2012
More...
|
Takeda Pharmaceutical Co. Ltd. (TKDG.DE) Reports Top-line Results From GEMINI II Pivotal Phase 3 Trial
5/11/2012
More...
|
Celgene Corporation (CELG) Release: The New England Journal of Medicine Reports on Three Phase III REVLIMID® (lenalidomide) Trials in Patients with Newly Diagnosed Multiple Myeloma
5/10/2012
More...
|
Novartis AG (NVS): Pasireotide Works Well in Phase III Acromegaly Trial
5/9/2012
More...
|
Roche (RHHBY) Abandons Cholesterol Drug Trial on Poor Results
5/8/2012
More...
|
Novartis AG (NVS) Drug for Smoker's Cough Boosts Lung Function in Study
5/3/2012
More...
|
Actelion Ltd. (ALIOF.PK) Surges as Hypertension Drug Meets Clinical Goal
5/1/2012
More...
|
Macrocure's CureXcell Shows Strong Efficacy and Safety in Phase IV Hard-To-Heal Wounds Trial
4/30/2012
More...
|
Forest Laboratories, Inc. (FRX) and Pierre Fabre Medicament Announce Third Positive Phase III Study for Levomilnacipran in Patients With Major Depressive Disorder
4/26/2012
More...
|
Novartis AG (NVS) Halts Hepatitis C Drug Trial After Death
4/24/2012
More...
|
RedHill Biopharma Ltd. Commences a Pivotal Bioequivalence Trial with RHB-103 (An Oral Thin Film for the Treatment of Migraine); Subjects' Recruitment Completed; First Dose Administered; Results Expected within Months
4/24/2012
More...
|
Sosei Group Corporation's QVA149 ILLUMINATE Phase III COPD Study Meets Primary Endpoint and Clarification of Anticipated Timing of US Filings for NVA237 and QVA149
4/24/2012
More...
|
Merck & Co., Inc. (MRK) Reports Phase III Study Results Evaluating Anemia Management Strategies Used With VICTRELIS® (boceprevir) Combination Therapy
4/19/2012
More...
|
GlaxoSmithKline (GSK) to File GLP-1 Diabetes Drug Albiglutide as Data Impresses
4/4/2012
More...
|
UCB, Inc. (UCBJF.PK) and Amgen (AMGN) Initiate Sclerostin Antibody Phase 3 Program in Patients With Postmenopausal Osteoporosis
4/4/2012
More...
|
Novartis AG (NVS) Lung Drug Meets Goals in Late-stage Trials
4/3/2012
More...
|
GlaxoSmithKline (GSK)'s New Once-daily HIV Drug Matches Merck & Co., Inc. (MRK) Rival
4/2/2012
More...
|
Amsterdam Molecular Therapeutics (AMT) (RHP.DE) Publishes Positive Data from Glybera® 14 Week Study
3/28/2012
More...
|
GlaxoSmithKline (GSK), Theravance, Inc. (THRX) Complete Registrational Program for Relovair; Reports Topline Results From Relovair(TM) vs. Advair(R) Phase III Studies in COPD
3/23/2012
More...
|
Starpharma Holdings Ltd Commences Pivotal Phase 3 Vivagel® Trials for Bacterial Vaginosis Treatment
3/22/2012
More...
|
AstraZeneca PLC (AZN), Targacept, Inc. (TRGT) Give Up on Antidepressant Drug After All Four Phase 3 Studies Fail
3/21/2012
More...
|
FDA Staff Questions Benefits of GlaxoSmithKline (GSK), Merck & Co., Inc. (MRK) Cancer Drugs
3/19/2012
More...
|
Genmab A/S (GEN.CO) Provides Update on Ofatumumab Phase III Head to Head Study in DLBCL
3/19/2012
More...
|
Phase III Study of Teva Pharmaceutical Industries Limited (TEVA)'s Oral Laquinimod Published in The New England Journal of Medicine Demonstrates Clinical Benefits for Multiple Sclerosis Patients
3/15/2012
More...
|
Tranzyme Pharma (TZYM) and Norgine Bowel Drug Fails Trial
3/12/2012
More...
|
Forest Laboratories, Inc. (FRX) and Pierre Fabre Medicament Announce Positive Phase III Results For Levomilnacipran in Patients With Major Depressive Disorder
3/7/2012
More...
|
BSD Medical (BSDM) Announces Hyperthermia Featured as the Fourth Pillar in Cancer Treatment at Annual Meeting of the German Cancer Society in Berlin, Germany
3/6/2012
More...
|
Meda AB (MEDA-A.ST): Positive Results for Dymista in Three Clinical Studies
3/5/2012
More...
|
Teva Pharmaceutical Industries Limited (TEVA) Reports Positive Phase III Findings From Late Stage Studies With QNASL Nasal Aerosol
3/5/2012
More...
|
Forest Laboratories, Inc. (FRX), Gedeon Richter Ltd. Schizophrenia Drug Meet Phase III Trial Goals
2/28/2012
More...
|
Ferring Pharmaceuticals, Inc. Release: FIRMAGON® (degarelix) Demonstrates Non-inferiority to goserelin with bicalutamide in Reducing Prostate Volume in Prostate Cancer Patients while Providing Better Relief from Lower Urinary Tract Symptoms
2/28/2012
More...
|
Tranzyme Pharma and Norgine Complete Enrollment in ULISES 008, the Second of Two Phase 3 Pivotal Trials of Ulimorelin
2/28/2012
More...
|